EMT inhibitor-1
EMT inhibitor-1 is an inhibitor of of Hippo, TGF-β, and Wnt signaling pathways with antitumor activities.
Product Specifications
CAS Number
1638526-21-2
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
Hippo (MST) ; TGF-beta/Smad; Wnt
Type
Reference compound
Related Pathways
Stem Cell/Wnt; TGF-beta/Smad
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/EMT_inhibitor-1.html
Purity
99.45
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
OCCCCOC1=NSN=C1C2=CC=C(Cl)C(Cl)=C2
Molecular Formula
C12H12Cl2N2O2S
Molecular Weight
319.21
Precautions
H302, H315, H319
References & Citations
[1]Basu D, et al. Identification, mechanism of action, and antitumor activity of a small molecule inhibitor of hippo, TGF-β, and Wnt signaling pathways. Mol Cancer Ther. 2014 Jun;13 (6) :1457-67.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400008-100 1x 100 µL
MAGE A1 (MA454), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470669-500 1x 500 µL
P27 / KIP1 (SX53G8), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471784-500 1x 500 µL
Histone H1 (Nuclear Marker) (HH1/1784R), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042819-500 1x 500 µL
Cytokeratin 18 (KRT18) (KRT18/2819R), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details